ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age [clear]
Topic Area [clear]
Experience
Course Format
SIG
Instructional Level
Results 81 - 90 of 97
Presenter(s): Pamela E Souza, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: According to recent research, an individual's success with using a hearing aid is connected to their cognitive ability. This course reviews the evidence and explains how to apply it to clinical decision-making to improve outcomes for each individual patient.
Presenter(s): Bethany L Kusek , MA, CCC-SLP; Andrea Elise Kremeier, MS, CCC-SLP, CBIS; Jett Mickelsen Stenson, MS, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: In the era of COVID-19, clinicians in health care settings have faced challenges in the evaluation and treatment of a new patient population - those who have had COVID-19 - requiring us to reframe our current treatment techniques. This session focuses on reinventing the speech-language pathologist's approach to treatment of respiratory activity tolerance for motor speech. It addresses collaboration with physical and occupational therapists for incorporation of dual motor tasks with more traditional treatment. Speakers discuss goal writing and tips for tracking measurable outcomes.
Presenter(s): Mark A. Parker, PhD, CCC-A, F-AAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The audiogram is a poor representation of a person's underlying otopathology and can therefore be a poor predictor of a person's hearing impairment. For example, persons with audiometric thresholds within normal limits may experience hearing impairment such as difficulty hearing in noise. Cochlear synaptopathy and outer hair cell dysfunction are two otopathologies undetected by the standard audiogram (a.k.a. Hidden Hearing Loss), but outer hair cell function plays a primary role in hearing in noise performance. A third undetected otopathology is cochlear untuning, which occurs secondary to outer hair cell damage. This course discusses each of these otopathologies and presents clinical normative data that can be used to differentially diagnose each otopathology.
Presenter(s): Vickie L. Tuten, AuD, CCC-A, CPS/A; Kathy E. Gates, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Noise is prevalent in everyday life, and the general population lacks awareness of the risks of hazardous noise exposure and strategies to reduce noise-induced hearing loss. By integrating hearing loss prevention education into patient encounters and taking advantage of outreach/education opportunities, audiologists can help reduce the prevalence of noise-induced hearing loss. This course discusses the why, where, and how of integrating prevention education into your practice.
Presenter(s): Stephanie J Karch, AuD, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This recorded session from the ASHA Audiology 2022 Online Conference explores the concept of hearing protection device (HPD) fit testing and various fit test methods. The speaker discusses application and use of HPD fit testing within occupational audiology and hearing conservation programs. The audience for this introductory session is any hearing health care professional and/or hearing conservationist who is interested in expanding their field of practice to include HPD fit testing.
Presenter(s): Callie Niemann, BS; Lindsey E Jorgensen, AuD, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hearing aids are fit by audiologists based on audiometric data. However, features within the hearing aids, and accessories added to the hearing aids, can add to or detract from patient benefit. This recorded session from the ASHA Audiology 2022 Online Conference describes and demonstrates the need for-and methods of-verification of features and accessories for hearing aids.
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted.
Presenter(s): Dave Fabry, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is no question that emerging technologies such as embedded sensors and artificial intelligence are changing the hearing health landscape. This session will look ahead to the coming decade and explore innovations in hearing health care technology, strategy, and service. The speaker will discuss practical ways to leverage these innovations to be successful in today’s and tomorrow’s dynamic market landscape.
Presenter(s): Meaghan Reed, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: It is unclear how over-the-counter hearing devices will impact our patients and our practices in the coming years. This session will discuss practical strategies for incorporating OTC devices, deciding when to offer alternative rehabilitation options to patients, and offering a wider variety of solutions to meet our patients’ needs.
Presenter(s): Stephanie Feller; Akbar Razvi, AuD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session covers a unique case of bilateral temporal bone fractures: one that spares the otic capsule yet presents with a large sensorineural component. The speaker describes the anatomy and physiology of the temporal bone to provide background information about potential structures that can be damaged in a fracture as well as explain the varying etiologies of temporal bone fractures (TBF). In addition, this session discusses possible outcomes from a TBF in relation to hearing loss and facial nerve function and potential implications for treatment, including cochlear implantation.
<< 1 2 3 4 5 6 7 8 9 10 >>